Neoadjuvant Therapy in Colon Cancer

Geerard L. Beets

doi:10.1007/978-3-031-59630-8_5

Neoadjuvant Therapy in Colon Cancer

Geerard L. Beets^*

^*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic

1 Downloads (Pure)

Abstract

Neoadjuvant therapy in colon cancer, traditionally reserved for rectal cancer, is gaining traction as a promising treatment strategy. This chapter offers a concise overview of neoadjuvant therapy in colon cancer, highlighting its evolving role, benefits, and challenges. The synopsis underscores the potential for neoadjuvant therapy to downstage tumours, improve surgical outcomes, and enhance overall survival. Understanding the evolving landscape of neoadjuvant therapy is vital for optimizing treatment strategies and improving outcomes in colon cancer patients.

Original language	English
Title of host publication	Coloproctology: A Practical Guide
Editors	Martyn Evans, Mark Davies, Rhiannon Harries, John Beynon
Publisher	Springer
Pages	133-146
Number of pages	14
ISBN (Electronic)	9783031596308
ISBN (Print)	9783031596292
DOIs	https://doi.org/10.1007/978-3-031-59630-8_5
Publication status	Published - 1 Jan 2024

Keywords

Chemotherapy
Colon cancer
Multimodal therapy
Neoadjuvant therapy
Oncological outcomes
Preoperative treatment
Radiation therapy
Response assessment
Surgical management
Tumour downstaging

Access to Document

10.1007/978-3-031-59630-8_5

Embargoed Document

Full Text
Final published version, 927 KB
Licence: Taverne
Embargo ends: 1/07/25
Request copy

Cite this

@inbook{7ef20e11874f4fe4a9c2a07bf5b250fa,

title = "Neoadjuvant Therapy in Colon Cancer",

abstract = "Neoadjuvant therapy in colon cancer, traditionally reserved for rectal cancer, is gaining traction as a promising treatment strategy. This chapter offers a concise overview of neoadjuvant therapy in colon cancer, highlighting its evolving role, benefits, and challenges. The synopsis underscores the potential for neoadjuvant therapy to downstage tumours, improve surgical outcomes, and enhance overall survival. Understanding the evolving landscape of neoadjuvant therapy is vital for optimizing treatment strategies and improving outcomes in colon cancer patients.",

keywords = "Chemotherapy, Colon cancer, Multimodal therapy, Neoadjuvant therapy, Oncological outcomes, Preoperative treatment, Radiation therapy, Response assessment, Surgical management, Tumour downstaging",

author = "Beets, {Geerard L.}",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing AG 2017.",

year = "2024",

month = jan,

day = "1",

doi = "10.1007/978-3-031-59630-8_5",

language = "English",

isbn = "9783031596292",

pages = "133--146",

editor = "Martyn Evans and Mark Davies and Rhiannon Harries and John Beynon",

booktitle = "Coloproctology: A Practical Guide",

publisher = "Springer",

address = "United States",

}

TY - CHAP

T1 - Neoadjuvant Therapy in Colon Cancer

AU - Beets, Geerard L.

N1 - Publisher Copyright: © Springer International Publishing AG 2017.

PY - 2024/1/1

Y1 - 2024/1/1

N2 - Neoadjuvant therapy in colon cancer, traditionally reserved for rectal cancer, is gaining traction as a promising treatment strategy. This chapter offers a concise overview of neoadjuvant therapy in colon cancer, highlighting its evolving role, benefits, and challenges. The synopsis underscores the potential for neoadjuvant therapy to downstage tumours, improve surgical outcomes, and enhance overall survival. Understanding the evolving landscape of neoadjuvant therapy is vital for optimizing treatment strategies and improving outcomes in colon cancer patients.

AB - Neoadjuvant therapy in colon cancer, traditionally reserved for rectal cancer, is gaining traction as a promising treatment strategy. This chapter offers a concise overview of neoadjuvant therapy in colon cancer, highlighting its evolving role, benefits, and challenges. The synopsis underscores the potential for neoadjuvant therapy to downstage tumours, improve surgical outcomes, and enhance overall survival. Understanding the evolving landscape of neoadjuvant therapy is vital for optimizing treatment strategies and improving outcomes in colon cancer patients.

KW - Chemotherapy

KW - Colon cancer

KW - Multimodal therapy

KW - Neoadjuvant therapy

KW - Oncological outcomes

KW - Preoperative treatment

KW - Radiation therapy

KW - Response assessment

KW - Surgical management

KW - Tumour downstaging

U2 - 10.1007/978-3-031-59630-8_5

DO - 10.1007/978-3-031-59630-8_5

M3 - Chapter

SN - 9783031596292

SP - 133

EP - 146

BT - Coloproctology: A Practical Guide

A2 - Evans, Martyn

A2 - Davies, Mark

A2 - Harries, Rhiannon

A2 - Beynon, John

PB - Springer

ER -

Neoadjuvant Therapy in Colon Cancer

Abstract

Keywords

Access to Document

Embargoed Document

Fingerprint

Cite this